CIK 0001671584
- Non-accelerated filer
- Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811567056
- Phone
- +1 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-18 | Mitchell Shawnte SVP, GC and Corporate Affairs | Grant or award · Stock Option (right to buy) | +134,800 | 134,800 | ||
| 2019-11-01 | Mitchell Shawnte SVP, GC and Corporate Affairs | Grant or award · Stock Option (right to buy) | +120,968 | 120,968 | ||
| 2019-03-01 | Mitchell Shawnte SVP, GC and Corporate Affairs | Option exercise | +6,787 | 82,539 | ||
| 2019-03-01 | Mitchell Shawnte SVP, GC and Corporate Affairs | Shares withheld for taxes | −2,012 | $1.57 | $3K | 80,527 |
| 2019-03-01 | Mitchell Shawnte SVP, GC and Corporate Affairs | Option exercise · Restricted Stock Unit | −6,787 | 0 | ||
| 2019-02-28 | Mitchell Shawnte SVP, GC and Corporate Affairs | Grant or award · Stock Option (right to buy) | +67,400 | 67,400 | ||
| 2018-08-09 | Mitchell Shawnte SVP, GC and Corporate Affairs | Option exercise | +1,630 | 76,135 | ||
| 2018-08-09 | Mitchell Shawnte SVP, GC and Corporate Affairs | Shares withheld for taxes | −383 | $4.50 | $2K | 75,752 |
| 2018-08-09 | Mitchell Shawnte SVP, GC and Corporate Affairs | Option exercise · Restricted Stock Units | −1,630 | 6,787 |
Page 1 of 1 · 9 trades